Baidu
map

Scand J Med Sci Sports:多踢球!有助于提高前驱糖尿病患者的骨骼健康

2019-02-16 不详 网络

本研究中,研究人员探究了在55至70岁的久坐不动的女性和患有前驱糖尿病的男性中,足球训练对骨骼健康的影响。将患有前驱糖尿病的患者(n = 50)(年龄; 61±9岁,BMI 29.7±0.6 kg/m2,体脂含量; 37±1%,VO2max; 22.7±0.8 mL/min / kg和平均动脉压; 104±将3mm Hg)随机分入足球训练组(FTG; n = 27,14名女性)和对照组(CON;

本研究中,研究人员探究了在55至70岁的久坐不动的女性和患有前驱糖尿病的男性中,足球训练对骨骼健康的影响。

将患有前驱糖尿病的患者(n = 50)(年龄; 61±9岁,BMI 29.7±0.6 kg/m2,体脂含量; 37±1%,VO2max; 22.7±0.8 mL/min / kg和平均动脉压; 104±将3mm Hg)随机分入足球训练组(FTG; n = 27,14名女性)和对照组(CON; n = 23,11名女性)。在基线时,分别有73%和24%的患者被诊断为股骨骨质减少和骨质疏松症。FTG在16周内每周两次进行30-60分钟的足球训练,FTG和CON都接受了专业的饮食建议。通过DXA扫描确定干预前和干预后的全身和区域骨矿物质含量(BMC)和密度(BMD),并抽取静脉血样并分析血浆骨转换标记物。

结果显示,与腿部BMD(0.023±0.005 vs -0.004±0.001 g/cm2)和腿部BMC(32±8 vs -4±6 g)中的CON相比,FTG的变化得分更高(P <0.05)。有利于FTG的组间变化(P <0.05)也发生在股骨颈BMD(3.2%)和股骨干骨密度(2.5%)。在干预期间,两组的全身BMC和BMD均未改变。在FTG中,静息血浆骨钙素,P1NP和CTX-1升高(P <0.05)23±8,52±9和38±7%,变化评分(P <0.05)高于CON。最后,从干预前和干预后,FTG(127±15 vs 150±11)的P1NP(形成)/CTX-1(再吸收)比率增加(P <0.05),CON没有变化(124±12和123) ±12)。

总之,该研究结果表明,足球训练提供了强大的成骨刺激,并改善了55至70岁的被诊断患有前驱糖尿病患者的骨骼健康。

原始出处:

Skoradal MB, Helge EW, et al., Osteogenic impact of football training in 55- to 70-year-old women and men with prediabetes. Scand J Med Sci Sports. 2018 Aug;28 Suppl 1:52-60. doi: 10.1111/sms.13252. Epub 2018 Jul 26.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1474706, encodeId=e3c914e470634, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Mon Feb 18 05:30:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555712, encodeId=68e71555e121c, content=<a href='/topic/show?id=9cac10191188' target=_blank style='color:#2F92EE;'>#骨骼健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101911, encryptionId=9cac10191188, topicName=骨骼健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b9814658686, createdName=meichuangyi, createdTime=Mon Feb 18 05:30:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609592, encodeId=aaa71609592b1, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Feb 18 05:30:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042254, encodeId=f9d9104225470, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Feb 16 17:30:00 CST 2019, time=2019-02-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1474706, encodeId=e3c914e470634, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Mon Feb 18 05:30:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555712, encodeId=68e71555e121c, content=<a href='/topic/show?id=9cac10191188' target=_blank style='color:#2F92EE;'>#骨骼健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101911, encryptionId=9cac10191188, topicName=骨骼健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b9814658686, createdName=meichuangyi, createdTime=Mon Feb 18 05:30:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609592, encodeId=aaa71609592b1, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Feb 18 05:30:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042254, encodeId=f9d9104225470, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Feb 16 17:30:00 CST 2019, time=2019-02-16, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1474706, encodeId=e3c914e470634, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Mon Feb 18 05:30:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555712, encodeId=68e71555e121c, content=<a href='/topic/show?id=9cac10191188' target=_blank style='color:#2F92EE;'>#骨骼健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101911, encryptionId=9cac10191188, topicName=骨骼健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b9814658686, createdName=meichuangyi, createdTime=Mon Feb 18 05:30:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609592, encodeId=aaa71609592b1, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Feb 18 05:30:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042254, encodeId=f9d9104225470, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Feb 16 17:30:00 CST 2019, time=2019-02-16, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1474706, encodeId=e3c914e470634, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Mon Feb 18 05:30:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555712, encodeId=68e71555e121c, content=<a href='/topic/show?id=9cac10191188' target=_blank style='color:#2F92EE;'>#骨骼健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101911, encryptionId=9cac10191188, topicName=骨骼健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b9814658686, createdName=meichuangyi, createdTime=Mon Feb 18 05:30:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609592, encodeId=aaa71609592b1, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Feb 18 05:30:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042254, encodeId=f9d9104225470, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Feb 16 17:30:00 CST 2019, time=2019-02-16, status=1, ipAttribution=)]
    2019-02-16 misszhang

    谢谢MedSci提供最新的资讯

    0

Baidu
map
Baidu
map
Baidu
map